"Designing Growth Strategies is in our DNA"

Antidepressants Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Selective Serotonin Reuptake Inhibitors, Serotonin & Norepinephrine Reuptake Inhibitors, Atypical Antidepressants, Tricyclic Antidepressants), By Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

Last Updated: January 20, 2025 | Format: PDF | Report ID: FBI105017

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD Billion)

Segmentation

  Drug Class; Disorder; Distribution Channel; and Region

By Drug Class

 

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
  • Atypical Antidepressants
  • Tricyclic Antidepressants (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Others

By Disorder

 

  • Major Depressive Disorder
  • Obsessive Compulsive Disorder
  • Generalized Anxiety Disorder
  • Panic Disorder
  • Others

By Distribution Channel

 

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography

 

  • North America
    • By Drug Class
    • By Disorder
    • By Distribution Channel
    • By Country
      • The USA (By Disorder)
      • Canada (By Disorder)
  • Europe
    • By Drug Class
    • By Disorder
    • By Distribution Channel
    • By Country
      • The UK (By Disorder)
      • Germany (By Disorder)
      • France (By Disorder)
      • Italy (By Disorder)
      • Spain (By Disorder)
      • Scandinavia (By Disorder)
      • Rest of Europe (By Disorder)
  • Asia Pacific
    • By Drug Class
    • By Disorder
    • By Distribution Channel
    • By Country
      • Japan (By Disorder)
      • China (By Disorder)
      • India (By Disorder)
      • Australia (By Disorder)
      • Southeast Asia (By Disorder)
      • Rest of Asia Pacific (By Disorder)
  • Latin America
    • By Drug Class
    • By Disorder
    • By Distribution Channel
    • By Country
      • Brazil (By Disorder)
      • Mexico (By Disorder)
      • Rest of Latin America (By Disorder)
  • The Middle East & Africa
    • By Drug Class
    • By Disorder
    • By Distribution Channel
    • By Country
      • GCC (By Disorder)
      • South Africa (By Disorder)
      • Rest of the MEA (By Disorder)
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X